# Advances in Imaging to Assess Response in Pancreatic Cancer (AIR-PANC)

> **NCT05727319** · — · COMPLETED · sponsor: **NHS Greater Glasgow and Clyde** · enrollment: 13 (actual)

## Conditions studied

- Pancreatic Ductal Adenocarcinoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05727319
- **Lead sponsor:** NHS Greater Glasgow and Clyde
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-11-17
- **Primary completion:** 2024-05-17
- **Final completion:** 2024-12-20
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2025-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05727319

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05727319, "Advances in Imaging to Assess Response in Pancreatic Cancer (AIR-PANC)". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT05727319. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*